187 related articles for article (PubMed ID: 18794120)
1. Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
Kwon M; Hanna E; Lorang D; He M; Quick JS; Adem A; Stevenson C; Chung JY; Hewitt SM; Zudaire E; Esposito D; Cuttitta F; Libutti SK
Cancer Res; 2008 Sep; 68(18):7332-41. PubMed ID: 18794120
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected].
Kwon M; Lee SJ; Reddy S; Rybak Y; Adem A; Libutti SK
PLoS One; 2013; 8(12):e82620. PubMed ID: 24340050
[TBL] [Abstract][Full Text] [Related]
3. Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.
Park YL; Park SY; Lee SH; Kim RB; Kim JK; Rew SY; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Oncotarget; 2016 Nov; 7(44):72229-72241. PubMed ID: 27750216
[TBL] [Abstract][Full Text] [Related]
4. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.
Burton ER; Gaffar A; Lee SJ; Adeshuko F; Whitney KD; Chung JY; Hewitt SM; Huang GS; Goldberg GL; Libutti SK; Kwon M
Mol Cancer Res; 2011 Aug; 9(8):1126-38. PubMed ID: 21693594
[TBL] [Abstract][Full Text] [Related]
6. Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.
Kwon M; Lee SJ; Wang Y; Rybak Y; Luna A; Reddy S; Adem A; Beaty BT; Condeelis JS; Libutti SK
Int J Cancer; 2014 Jul; 135(1):48-60. PubMed ID: 24327474
[TBL] [Abstract][Full Text] [Related]
7. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
8. FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.
Kwon M; Rubio G; Nolan N; Auteri P; Volmar JA; Adem A; Javidian P; Zhou Z; Verzi MP; Pine SR; Libutti SK
Cancer Res; 2021 Nov; 81(21):5523-5539. PubMed ID: 34417201
[TBL] [Abstract][Full Text] [Related]
9. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
[TBL] [Abstract][Full Text] [Related]
10. Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.
Ou-Yang F; Lan KL; Chen CT; Liu JC; Weng CL; Chou CK; Xie X; Hung JY; Wei Y; Hortobagyi GN; Hung MC
Cancer Res; 2006 Jan; 66(1):378-84. PubMed ID: 16397252
[TBL] [Abstract][Full Text] [Related]
11. Filamin A interacting protein 1-like as a therapeutic target in cancer.
Kwon M; Libutti SK
Expert Opin Ther Targets; 2014 Dec; 18(12):1435-47. PubMed ID: 25200207
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.
Zou X; Qiao H; Jiang X; Dong X; Jiang H; Sun X
J Biomed Sci; 2009; 16(1):33. PubMed ID: 19292890
[TBL] [Abstract][Full Text] [Related]
14. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
[TBL] [Abstract][Full Text] [Related]
15. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.
Kaur B; Cork SM; Sandberg EM; Devi NS; Zhang Z; Klenotic PA; Febbraio M; Shim H; Mao H; Tucker-Burden C; Silverstein RL; Brat DJ; Olson JJ; Van Meir EG
Cancer Res; 2009 Feb; 69(3):1212-20. PubMed ID: 19176395
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin.
Diao Y; Ma J; Xiao WD; Luo J; Li XY; Chu KW; Fung P; Habib N; Farzaneh F; Xu RA
World J Gastroenterol; 2007 Sep; 13(34):4615-9. PubMed ID: 17729417
[TBL] [Abstract][Full Text] [Related]
18. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
19. AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
Nie B; Shen Z; Wen JB; Wong OG; Hsueh WD; Huo LF; Kung HF; Jiang B; Lin MC
Mol Cancer Ther; 2008 Sep; 7(9):2855-65. PubMed ID: 18790766
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
